Pegylated Interferon-α2b and Lamivudine in Hepatitis B e Antigen-Positive Chronic Hepatitis B
- Martijn J. ter Borg, MD; and
- Harry L.A. Janssen, MD, PhD
- From Erasmus Medical Center Rotterdam, 3015 GD Rotterdam, the Netherlands.
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for …
RSS Feeds









